CA 125 levels in the preoperative assessment of advanced-stage uterine cancer

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 5, 2003, Pages 1195-1197

  Jhang, Helen ^a,b   Chuang, Linus ^a   Visintainer, Paul ^a   Ramaswamy, Gita ^a  

^a WESTCHESTER MEDICAL CENTER   (United States)

^b University OB/GYN PC   (United States)

Author keywords

Advanced stage; CA 125; Preoperative assessment; Uterine cancer

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MYOMETRIUM; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UTERUS CANCER;

EID: 0038057668     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.304     Document Type: Article

References (10)

1. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer: a Gynecologic Oncology Group study. Cancer 1987;60:2035-41.
2. van Doorn HC, van der Zee AG, Peeters PH, Krocks MV, van Eükeren MA. Preoperative selection of patients with low stage endometrial cancer at high risk for pelvic lymph node metastases. Int J Gynecol Cancer 2002;12:144-8.
3. Hardesty LA, Sumkin JH, Hakim C, Jones C, Nath M. The ability of helical CT to preoperatively stage endometrial cancer. Am J Roentgenol 2001;176:603-6.
4. Zerbe MJ, Bristow R, Grumbine FC, Montz FJ. Inability of preoperative computed tomography scans to accurately predict the extent of myometrial invasion and extra corporal spread in endometrial cancer. Gynecol Oncol 2000;78:67-70.
5. Hsieh CH, Chang-Chien CC, Lin H, Huang EY, Huang CC, Lan CK, et al. Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer? Gynecol Oncol 2002;86:28-33.
6. Dotters DJ. Preoperative CA 125 in endometrial cancer: is it useful? Am J Obstet Gynecol 2000;182:1328-34.
7. Koper NP, Massuger LF, Thomas CM, Kiemeney LA, Verbeek AL. Serum CA 125 measurements to identify patients with endometrial cancer who require lymphadenectomy. Anticancer Res 1998;18:1897-902.
8. Otah S, Sugiyama T, Ushijima K, Komai K, Fujiyoshi K, Hirai N, et al. Successful treatment of 2 patients with recurrent endometrial cancer by weekly paclitaxel. Cancer Lett 2000;160:9-12.
9. Rose PG, Sommers RM, Reale FR, Hunter RE, Fournier L, Nelson BE. Serial serum CA 125 measurements for the evaluation of recurrences in patients with endometrial cancer. Obstet Gynecol 1994;84:12-6.
10. Fujimara H, Kikkawa F, Oguchi H, Nakashima N, Mizutani S. Adjuvant chemotherapy including cisplatin in endometrial cancer. Gynecol Obstet Invest 2000;50:127-32.